Published in Exp Physiol on May 01, 1999
Acute effect of the dual angiotensin-converting enzyme and neutral endopeptidase 24-11 inhibitor mixanpril on insulin sensitivity in obese Zucker rat. Br J Pharmacol (2001) 0.87
The renin angiotensin system and the metabolic syndrome. Open Hypertens J (2010) 0.86
The B2 receptor of bradykinin is not essential for the post-exercise increase in glucose uptake by insulin-stimulated mouse skeletal muscle. Physiol Res (2011) 0.82
Plasma Protein Biomarkers Correlated with the Development of Diet-Induced Type 2 Diabetes in Mice. Clin Proteomics (2010) 0.79
Postexercise skeletal muscle glucose transport is normal in kininogen-deficient rats. Med Sci Sports Exerc (2011) 0.78
Preclinical characterization of recombinant human tissue kallikrein-1 as a novel treatment for type 2 diabetes mellitus. PLoS One (2014) 0.78
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats. Br J Pharmacol (2001) 0.78
Evidence and evidence gaps of medical treatment of non-tumorous diseases of the head and neck. GMS Curr Top Otorhinolaryngol Head Neck Surg (2016) 0.75
Arabidopsis mutants impaired in cosuppression. Plant Cell (1998) 2.58
Risk of developing retinopathy in Diabetes Control and Complications Trial type 1 diabetic patients with good or poor metabolic control. Diabetes Care (2001) 2.11
Impaired immune responses in diabetes mellitus: analysis of the factors and mechanisms involved. Relevance to the increased susceptibility of diabetic patients to specific infections. Diabete Metab (1992) 1.62
Non-alcoholic steatohepatitis: association with obesity and insulin resistance, and influence of weight loss. Diabetes Metab (2000) 1.45
Glucagon secretion in diabetic patients with idiopathic haemochromatosis. Diabetologia (1977) 1.42
TETRASPORE encodes a kinesin required for male meiotic cytokinesis in Arabidopsis. Plant J (2003) 1.36
The signal transducer and activator of transcription STAT5b gene is a new partner of retinoic acid receptor alpha in acute promyelocytic-like leukaemia. Hum Mol Genet (1999) 1.18
Presence of pancreatic glucagon in the portal plasma of human neonates. Differences in the insulin and glucagon responses to glucose between normal infants and infants from diabetic mothers. Diabetologia (1972) 1.15
Vitamin E reduction of protein glycosylation in diabetes. New prospect for prevention of diabetic complications? Diabetes Care (1991) 1.12
The contribution of germline rearrangements to the spectrum of BRCA2 mutations. J Med Genet (2006) 1.00
Arguments for a regulation of pancreatic glucagon secretion by circulating plasma free fatty acids. Proc Soc Exp Biol Med (1970) 0.98
Changes in glucose turnover parameters and improvement of glucose oxidation after 4-week magnesium administration in elderly noninsulin-dependent (type II) diabetic patients. J Clin Endocrinol Metab (1994) 0.95
Kinins and peritoneal exudates induced by carrageenin and zymosan in rats. Br J Pharmacol (1990) 0.93
Expression in transgenic mice of the large T antigen of polyomavirus induces Sertoli cell tumours and allows the establishment of differentiated cell lines. Oncogene (1993) 0.92
Mechanisms involved in the exercise-induced increase in glucagon secretion in rats. Diabetes (1974) 0.92
Plasma glucagon levels in normal women during pregnancy. Diabetologia (1975) 0.90
Quantification of rat T-kininogen using immunological methods. Application to inflammatory processes. Biochem Pharmacol (1989) 0.89
Catecholamines and exercise-induced glucagon and fatty acid mobilization in the rat. Am J Physiol (1975) 0.89
Glucagon and diabetes: a reappraisal. Diabetologia (1979) 0.88
Effects of pulsatile delivery of insulin and glucagon in humans. Am J Physiol (1989) 0.88
Letter: Potentiation of hypoglycemic effect of sulfonylureas by clofibrate. N Engl J Med (1976) 0.88
Effect of acute kidney exclusion by ligation of renal arteries on peripheral plasma glucagon levels and pancreatic glucagon production in the anesthetized dog. Metabolism (1975) 0.88
Glucose and insulin in the regulation of glucagon release from the isolated perfused dog stomach. Endocrinology (1978) 0.87
Influence of several peptidase inhibitors on the pro-inflammatory effects of substance P, capsaicin and collagenase. Naunyn Schmiedebergs Arch Pharmacol (1996) 0.86
Biological properties of a transplantable islet-cell tumor of the golden hamster. 3. Electron microscopic studies. Diabetes (1968) 0.86
The intra-nasal administration of insulin induces significant hypoglycaemia and classical counterregulatory hormonal responses in normal man. Diabete Metab (1988) 0.86
Renal handling of endogenous glucagon in the dog: comparison with insulin. Metabolism (1974) 0.86
Rare germline large rearrangements in the BRCA1/2 genes and eight candidate genes in 472 patients with breast cancer predisposition. Breast Cancer Res Treat (2012) 0.85
Anti-oxidants show an anti-hypertensive effect in diabetic and hypertensive subjects. Clin Sci (Lond) (1991) 0.84
Biological properties of a transplantable islet-cell tumor of the golden hamster. II. Insulin content of the tumor and some metabolic characteristics of the tumor-bearing animals. Diabetes (1967) 0.84
Plasma glucagon after kidney exclusion: experiments in somatostatin-infused and in eviscerated dogs. Metabolism (1976) 0.83
First large rearrangement in the MUTYH gene and attenuated familial adenomatous polyposis syndrome. Clin Genet (2011) 0.83
Muscular exercise and pancreatic function in rats. Isr J Med Sci (1972) 0.83
Fate of exogenous glucose during exercise of different intensities in humans. J Appl Physiol Respir Environ Exerc Physiol (1982) 0.83
Similar metabolic effects of pulsatile versus continuous human insulin delivery during euglycemic, hyperinsulinemic glucose clamp in normal man. Diabetes (1984) 0.82
Effects of gastroplasty on body weight and related biological abnormalities in morbid obesity. Diabetes Metab (1998) 0.82
[Stimulation by carbamylcholine of dog gastric-glucagon release (author's transl) (proceedings)]. Ann Endocrinol (Paris) (1979) 0.82
Effect of oleic acid on insulin secretion by the isolated perfused rat pancreas. Diabetologia (1979) 0.82
Stimulation of insulin secretion after prostaglandin PGE 1 in the anesthetized dog. Biochem Pharmacol (1973) 0.82
Retinopathy, but not neuropathy, is influenced by the level of residual endogenous insulin secretion in type 2 diabetes. Diabete Metab (1995) 0.81
[Arachidonic acid release by bradykinin]. C R Seances Soc Biol Fil (1974) 0.81
Pro-inflammatory flavonoids which are inhibitors of prostaglandin biosynthesis. Prostaglandins Leukot Med (1985) 0.81
Lipids and lipoproteins in chronic uraemia. A study of the influence of regular haemodialysis. Eur J Clin Invest (1976) 0.80
Long-term effects of oral estradiol and dydrogesterone on carbohydrate metabolism in postmenopausal women. Climacteric (1999) 0.80
Thymic expression of insulin-related genes in an animal model of autoimmune type 1 diabetes. Diabetes Metab Res Rev (2001) 0.80
Insulin oscillations per se do not affect glucose turnover parameters in normal man. J Clin Endocrinol Metab (1986) 0.80
Metabolic adaptation to prolonged exercise in severely obese subjects. Int J Obes (1983) 0.80
Independance of glucagon and insulin handling by the isolated perfused dog kidney. Diabetologia (1976) 0.80
[Bronchial reactivity in diabetic patients]. Rev Mal Respir (1997) 0.79
Evidence that insulin-like growth factor 2 (IGF2) is the dominant thymic peptide of the insulin superfamily. Thymus (1993) 0.79
Hormonal and metabolic adaptation to protein-supplemented fasting in obese subjects. Int J Obes (1982) 0.79
Effect of insulin on glucagon enhanced lipolysis in vitro. Diabetologia (1969) 0.79
Ultrastructural and biochemical evidence for gap junction and connexin 43 expression in a clonal Sertoli cell line: a potential model in the study of junctional complex formation. Cell Tissue Res (1998) 0.79
Changes in blood glucose and plasma insulin levels induced by bradykinin in anaesthetized rats. Br J Pharmacol (2001) 0.78
Presence of T-kininogen and kinins in sponge-induced exudates in rats. Br J Pharmacol (1989) 0.78
Pharmacological compounds affecting plasma glucagon levels in rats. Biochem Pharmacol (1976) 0.78
Pituitary-testicular axis in diabetic men with and without sexual impotence. Diabete Metab (1978) 0.78
Evidence of somatic mosaicism for a MECP2 mutation in females with Rett syndrome: diagnostic implications. J Med Genet (2001) 0.78
Effect of ouabain on insulin secretion in the anesthetized dog. Biochem Pharmacol (1972) 0.78
Pharmacological treatment of the obese diabetic patient. Diabete Metab (1994) 0.78
Vagal stimulation and its role in eliciting gastrin but not glucagon release from the isolated perfused dog stomach. Gut (1978) 0.78
Inhibition by somatostatin of carbamylcholine-induced gastrin and glucagon release from the isolated perfused canine stomach. Gut (1981) 0.78
Influence of metformin on arginine-induced glucagon secretion in human diabetes. Diabete Metab (1975) 0.78
Platelet-activating factor and the vascular effects of zymosan in rats. Eur J Pharmacol (1993) 0.78
Interrelationships glucagon-adrenergic system in experimental and clinical conditions. Arch Int Pharmacodyn Ther (1968) 0.78
Effect of L8027, a new potent inhibitor of prostaglandin biosynthesis, on the metabolism and response to glucagon of rat adipose tissue. Biochem Pharmacol (1974) 0.78
Availability of glucose given orally during exercise. J Appl Physiol Respir Environ Exerc Physiol (1984) 0.77
Historical and methodological aspects of computer-assisted medical history-taking. Med Inform (Lond) (1986) 0.77
[Advantages of pulsatile administration of human insulin on endogenous pancreatic secretion in the normal subject and in type 1 diabetics]. Ann Med Interne (Paris) (1988) 0.77
Possible role of endogenous prostaglandins in glucagon secretion by isolated guinea-pig islets. Diabetologia (1978) 0.77
Influence of elevated plasma free fatty acids on the glucagon response to hypoglycemia in normal and in pregnant women. Metabolism (1978) 0.77
The involvement of the opioid system in human obesity: a study in normal weight relatives of obese people. J Clin Endocrinol Metab (1996) 0.77
Detection of early sympathetic cardiovascular neuropathy by squatting test in NIDDM. Diabetes Care (1994) 0.77
Proteinase inhibitors, kinins and the inflammatory reaction induced by sponge implantation in rats. Eur J Pharmacol (1990) 0.77
[Hydroxylation and defluorination of fluorinated derivatives of aniline]. Arch Int Pharmacodyn Ther (1968) 0.77
Clinical aspects of the relationship between oral contraceptives, abnormalities in carbohydrate metabolism, and the development of cardiovascular disease. Am J Obstet Gynecol (1990) 0.77
Pulsatile hyperglucagonemia fails to increase hepatic glucose production in normal man. Am J Physiol (1987) 0.77
The breakfast tolerance test: a return to physiology. Diabete Metab (1976) 0.77
Effect of physical training on utilization of a glucose load given orally during exercise. Am J Physiol (1984) 0.77
Glibenclamide pharmacokinetics in acarbose-treated type 2 diabetics. Eur J Clin Pharmacol (1984) 0.76
Cardiovascular risk factors in a sample of a rural Belgian population: the Bellux MONICA Study. Acta Med Scand Suppl (1988) 0.76
Studies on the pathogenesis of reactive hypoglycemia: role of insulin and glucagon. Horm Metab Res (1976) 0.76
[Cardiovascular prevention: could the polypill reduce the risk of clinical inertia and poor compliance?]. Rev Med Liege (2010) 0.76
Reduction of the acute bioavailability of metformin by the alpha-glucosidase inhibitor acarbose in normal man. Eur J Clin Invest (1994) 0.76
The myostimulating effect of tissue kallikrein on rat uterus. Naunyn Schmiedebergs Arch Pharmacol (1995) 0.76
Effects of acetylsalicylic acid on blood glucose, plasma FFA, glycerol, 3-hydroxybutyrate, alanine, C-peptide, glucagon and growth hormone responses to arginine in insulin-dependent diabetics. Diabete Metab (1980) 0.76
[Diabetes in the Belgian province of Luxembourg: frequency, importance of the oral glucose tolerance test and a modestly increased fasting blood glucose]. Diabete Metab (1991) 0.76
Clofibrate and diabetes control in patients treated with oral hypoglycaemic agents. Br J Clin Pharmacol (1979) 0.75
Glipizide increases plasma insulin but not C-peptide level after a standardized breakfast in type 2 diabetic patients. Eur J Clin Pharmacol (1984) 0.75
Remarkable metabolic availability of oral glucose during long-duration exercise in humans. J Appl Physiol (1985) (1986) 0.75
Localization of insulinoma by intraoperative ultrasonography. J R Soc Med (1989) 0.75
Persistence of altered metabolic responses to beta-endorphin after normalization of body weight in human obesity. Acta Endocrinol (Copenh) (1991) 0.75
Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months. Diabetologia (1981) 0.75
[United Kingdom Prospective Diabetes Study (UKPDS): 10 years later]. Rev Med Liege (2008) 0.75
[Insulin glargine and cancer: a storm in a glass of water?]. Rev Med Liege (2009) 0.75
[Clinical cases, a panacea view of medicine: from the simple anecdote to teaching practice]. Rev Med Liege (2009) 0.75
[The direct effect of cystamine on the secretion of glucocorticoids from the adrenal glands of the neck in the dog]. Arch Int Pharmacodyn Ther (1970) 0.75
[Measurement of tryptophan 5-hydroxylase in rat brain]. Arch Int Physiol Biochim (1972) 0.75
[Cortisol and corticosterone secretion by adrenal glands transplanted to the neck in dogs]. C R Seances Soc Biol Fil (1972) 0.75
[Circadian rhythm in normal man]. Arch Int Physiol Biochim (1971) 0.75